BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 32446561)

  • 1. Antioxidants suppress radiation-induced apoptosis via inhibiting MAPK pathway in nasopharyngeal carcinoma cells.
    Meng DF; Guo LL; Peng LX; Zheng LS; Xie P; Mei Y; Li CZ; Peng XS; Lang YH; Liu ZJ; Wang MD; Xie DH; Shu DT; Hu H; Lin ST; Li HF; Luo FF; Sun R; Huang BJ; Qian CN
    Biochem Biophys Res Commun; 2020 Jun; 527(3):770-777. PubMed ID: 32446561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dehydrocrenatidine extracted from
    Hsieh MC; Lo YS; Chuang YC; Lin CC; Ho HY; Hsieh MJ; Lin JT
    Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34165177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting CPT1A-mediated fatty acid oxidation sensitizes nasopharyngeal carcinoma to radiation therapy.
    Tan Z; Xiao L; Tang M; Bai F; Li J; Li L; Shi F; Li N; Li Y; Du Q; Lu J; Weng X; Yi W; Zhang H; Fan J; Zhou J; Gao Q; Onuchic JN; Bode AM; Luo X; Cao Y
    Theranostics; 2018; 8(9):2329-2347. PubMed ID: 29721083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of 3-bromopyruvate in human nasopharyngeal carcinoma cells.
    Zou X; Zhang M; Sun Y; Zhao S; Wei Y; Zhang X; Jiang C; Liu H
    Oncol Rep; 2015 Oct; 34(4):1895-904. PubMed ID: 26239511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SALL4 induces radioresistance in nasopharyngeal carcinoma via the ATM/Chk2/p53 pathway.
    Nie X; Guo E; Wu C; Liu D; Sun W; Zhang L; Long G; Mei Q; Wu K; Xiong H; Hu G
    Cancer Med; 2019 Apr; 8(4):1779-1792. PubMed ID: 30907073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetrandrine Induces Apoptosis of Human Nasopharyngeal Carcinoma NPC-TW 076 Cells through Reactive Oxygen Species Accompanied by an Endoplasmic Reticulum Stress Signaling Pathway.
    Lin YJ; Peng SF; Lin ML; Kuo CL; Lu KW; Liao CL; Ma YS; Chueh FS; Liu KC; Yu FS; Chung JG
    Molecules; 2016 Oct; 21(10):. PubMed ID: 27754332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salinomycin overcomes radioresistance in nasopharyngeal carcinoma cells by inhibiting Nrf2 level and promoting ROS generation.
    Zhang G; Wang W; Yao C; Ren J; Zhang S; Han M
    Biomed Pharmacother; 2017 Jul; 91():147-154. PubMed ID: 28453992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effect of TMZ-POH on human nasopharyngeal carcinoma depends on reactive oxygen species accumulation.
    Xie L; Song X; Guo W; Wang X; Wei L; Li Y; Lv L; Wang W; Chen TC; Song X
    Oncotarget; 2016 Jan; 7(2):1651-62. PubMed ID: 26625208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triptolide Combined with Radiotherapy for the Treatment of Nasopharyngeal Carcinoma via NF-κB-Related Mechanism.
    Zhang W; Kang M; Zhang T; Li B; Liao X; Wang R
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the Numb/Notch signaling pathway increases radiation sensitivity in human nasopharyngeal carcinoma cells.
    Shen ED; Zeng Q
    Kaohsiung J Med Sci; 2019 Aug; 35(8):474-485. PubMed ID: 31271505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting nasopharyngeal carcinoma by artesunate through inhibiting Akt/mTOR and inducing oxidative stress.
    Li Q; Ni W; Deng Z; Liu M; She L; Xie Q
    Fundam Clin Pharmacol; 2017 Jun; 31(3):301-310. PubMed ID: 28078787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pectolinarigenin Suppresses the Tumor Growth in Nasopharyngeal Carcinoma.
    Wang C; Cheng Y; Liu H; Xu Y; Peng H; Lang J; Liao J; Liu H; Liu H; Fan J
    Cell Physiol Biochem; 2016; 39(5):1795-1803. PubMed ID: 27744436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium butyrate induces autophagic apoptosis of nasopharyngeal carcinoma cells by inhibiting AKT/mTOR signaling.
    Huang W; Zeng C; Liu J; Yuan L; Liu W; Wang L; Zhu H; Xu Y; Luo Y; Xie D; Jiang X; Ren C
    Biochem Biophys Res Commun; 2019 Jun; 514(1):64-70. PubMed ID: 31023529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caffeic acid phenethyl ester suppressed growth and metastasis of nasopharyngeal carcinoma cells by inactivating the NF-κB pathway.
    Liang Y; Feng G; Wu L; Zhong S; Gao X; Tong Y; Cui W; Qin Y; Xu W; Xiao X; Zhang Z; Huang G; Zhou X
    Drug Des Devel Ther; 2019; 13():1335-1345. PubMed ID: 31118570
    [No Abstract]   [Full Text] [Related]  

  • 15. Knockdown of LAMB3 suppressed radioresistance in nasopharyngeal carcinoma via deactivating NRF2 signaling pathway.
    Zhuang Q; Liu G; Huang W; He Z
    J Radiat Res; 2023 May; 64(3):509-519. PubMed ID: 36947579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cinobufagin induces cell cycle arrest at the S phase and promotes apoptosis in nasopharyngeal carcinoma cells.
    Pan Z; Luo Y; Xia Y; Zhang X; Qin Y; Liu W; Li M; Liu X; Zheng Q; Li D
    Biomed Pharmacother; 2020 Feb; 122():109763. PubMed ID: 31918288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bortezomib and SAHA synergistically induce ROS-driven caspase-dependent apoptosis of nasopharyngeal carcinoma and block replication of Epstein-Barr virus.
    Hui KF; Lam BH; Ho DN; Tsao SW; Chiang AK
    Mol Cancer Ther; 2013 May; 12(5):747-58. PubMed ID: 23475956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APLNR is involved in ATRA-induced growth inhibition of nasopharyngeal carcinoma and may suppress EMT through PI3K-Akt-mTOR signaling.
    Liu Y; Liu Q; Chen S; Liu Y; Huang Y; Chen P; Li X; Gao G; Xu K; Fan S; Zeng Z; Xiong W; Tan M; Li G; Zhang W
    FASEB J; 2019 Nov; 33(11):11959-11972. PubMed ID: 31408612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXO3a knockdown promotes radioresistance in nasopharyngeal carcinoma by inducing epithelial-mesenchymal transition and the Wnt/β-catenin signaling pathway.
    Luo M; Wu C; Guo E; Peng S; Zhang L; Sun W; Liu D; Hu G; Hu G
    Cancer Lett; 2019 Jul; 455():26-35. PubMed ID: 31022422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PGC1α/CEBPB/CPT1A axis promotes radiation resistance of nasopharyngeal carcinoma through activating fatty acid oxidation.
    Du Q; Tan Z; Shi F; Tang M; Xie L; Zhao L; Li Y; Hu J; Zhou M; Bode A; Luo X; Cao Y
    Cancer Sci; 2019 Jun; 110(6):2050-2062. PubMed ID: 30945396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.